Innovating in a downturn

The cost savings from reduced R&D expenditure are undoubtedly attractive, but are they false economies? Will those companies pulling back from longer term development find themselves without the products or services capable of generating the thrust to power out of a recession? The current issue of  The Gen examines how to survive the downturn and position for the upturn.

Investing in healthcare 2009

The UK healthcare industry has remained resilient, stable and remarkably active through the current financial volatility. Join Sagentia's Dan Flicos as he talks about what the medtech business environment offers investors.

Intellectual Property Analysis & Strategy

It is well recognised that patented intellectual property (IP) plays a crucial role in ensuring an organisation's curent and future prosperity. Not so well known are the arts of how to construct and manage a patent portfolio in light of a constantly changing external IP landscape.